BioNTech's cancer vaccine setback triggered sector-wide biotech selloff, dragging Arcturus and Moderna lower.
Why it matters
BioNTech's cancer vaccine setback triggered sector-wide biotech selloff, dragging Arcturus and Moderna lower. — impact context not separately stored; see What changed.